secwatch / observer
8-K filed November 5, 2024, 6:59 PM ET ticker STME CIK 0001493712
other material confidence high sentiment neutral materiality 0.45

Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics

Stimcell Energetics Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Stimcell Energetics Inc.: Company amended its articles of incorporation to change name from Cell MedX Corp. to Stimcell Energetics Inc (effective 2024-11-01).

Change
charter amendment
Effective
2024-11-01
Exact text from the filing
Concurrent with the Reverse Split, the Company amended its articles of incorporation to change the Company’s name from “Cell MedX Corp.” to “Stimcell Energetics Inc.” (the “Name Change”)
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Stimcell Energetics Inc.: Company completed a 1-for-15 reverse stock split and decreased authorized capital from 7,500,000,000 to 500,000,000 shares via amendment to articles of incorporation (effective 2024-11-01).

Change
charter amendment
Effective
2024-11-01
Exact text from the filing
1:15 Reverse Stock Split Effective November 1, 2024, Cell MedX Corp. (the “Company”) completed a 1-for-15 reverse split (the “Reverse Split”) of its common stock. As a result of the Reverse Split, the Company’s authorized capital was decreased from 7,500,000,000 shares common stock, par value $0.001, of which 297,236,373 shares of common stock were outstanding immediately prior to the Reverse Split, to 500,000,000 shares of common stock, par value $0.001, of which approximately 19,815,758 are outstanding, subject to adjustment for fractional interests resulting from the Reverse Split.
View on SEC.gov

Browse all governance changes →

Stimcell Energetics Inc. filing history →

Source: SEC EDGAR
accession 0001393905-24-000378
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.